Perretti M, Ahluwalia A
Department of Biochemical Pharmacology, The William Harvey Research Institute, London, England.
Microcirculation. 2000 Jun;7(3):147-61.
The glucocorticoid hormones and their synthetic derivatives are potent suppressors of inflammatory and allergic pathologies. Their widespread efficacy is the result of multiple modes of action occurring predominantly at the level of the microcirculation. Indeed the glucocorticoids interfere with the function of all of the cellular components of the microcirculation associated with an inflammatory response. These agents inhibit vasodilatation of the arteriolar and capillary beds. therefore preventing the increase in blood flow that characterizes the initial stages of the inflammatory response. They also prevent increases in vascular permeability in the capillary and post-capillary venule, thereby reducing exudate formation. Finally, the glucocorticoids potently suppress leukocyte emigration across post-capillary venules. However, this promiscuity of the glucocorticoids to act at multiple sites also endows this class of (drugs with major side effects associated with chronic treatment. We propose that one way to progress forward is to understand better the effects of glucocorticoids within the microcirculation. This may aid identification of specific molecular sites of action and therefore the development of novel glucocorticoid molecules with fewer side effects.
糖皮质激素及其合成衍生物是炎症和过敏性疾病的强效抑制剂。它们广泛的疗效源于主要在微循环水平上发生的多种作用方式。实际上,糖皮质激素会干扰与炎症反应相关的微循环所有细胞成分的功能。这些药物会抑制小动脉和毛细血管床的血管舒张,从而防止出现作为炎症反应初始阶段特征的血流增加。它们还能防止毛细血管和毛细血管后微静脉的血管通透性增加,从而减少渗出物形成。最后,糖皮质激素能有效抑制白细胞跨毛细血管后微静脉的渗出。然而,糖皮质激素在多个部位发挥作用的这种 indiscriminate 性也赋予了这类药物与长期治疗相关的主要副作用。我们认为,前进的一种方法是更好地了解糖皮质激素在微循环中的作用。这可能有助于确定特定的分子作用位点,从而开发出副作用更少的新型糖皮质激素分子。 (注:原文中“promiscuity”这里翻译为“ indiscriminate ”可能不太准确,可考虑“不加区分性”等更合适的表述,但按照要求未做修改)